Companies Investors People

Loading

aVenture is in Beta: research coverage is expanding as we build, so please independently verify key details before making investment decisions.

aVenture is in Beta: research coverage is expanding as we build, so please independently verify key details before making investment decisions.

Get in Touch

Contact
Request a Demo
Request Data Updates
Add a Company

Research

Companies
Investors
People

aVenture

Download App
Pricing

Resources

Documentation
Use Cases
CLI
MCP
Feature Requests
Sitemap

Member

Backed by

Ask AI about aVenture

© aVenture Investment Company, 2026. All rights reserved.

San Francisco, CA, USA

Privacy · Terms of Service

aVenture Investment Company ("aVenture") is an independent research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals. It is not a registered investment adviser, broker-dealer, or investment advisor and does not provide investment advice or recommendations. The data provided by aVenture does not constitute recommendations or advice, whether by methodology, analysis, AI-generated content, or a statement written by a staff member of aVenture.

aVenture is not affiliated with any of the people, companies, organizations, government agencies, regulatory bodies, or investment funds we provide coverage for on this site unless explicitly stated otherwise. Users assume full responsibility for decisions made based on information obtained from this platform. Links to external websites do not imply endorsement or affiliation with aVenture. Any links that provide the ability to invest in a primary or secondary transaction in a company are for convenience only and do not constitute solicitations or offers to buy or sell an investment. Investors should exercise heightened precaution and due diligence when investing in private companies, especially those not independently audited.

While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision. To the fullest extent permitted by law, aVenture shall not be liable for any direct, indirect, incidental, consequential, or financial damages arising from use of this site, whether by consumers of its contents directly or by persons or organizations covered by our research, even if we are advised of the possibility. Our best-efforts processes and correction request forms do not create a warranty or duty of care.

Profiles on this platform may include content generated in part by large language models (LLMs, artificial intelligence) that aggregate publicly available sources (e.g., SEC EDGAR, public filings, press releases). Source attribution is provided where known; always verify statements and claims here against original sources before relying on any data. Content on our site may contain inaccuracies, omissions, or what are commonly called 'hallucinations' if generated in part or in full by AI / LLMs. The risk can also exist even when content is written by a human, as internal and third-party sources may also have inaccuracies for the same or different reasons. While we randomly audit a proportion of content, this is not exhaustive.

We recommend that an independent auditor be hired to verify the accuracy of the information before relying on it for any sensitive decisions. By accessing this platform, you agree not to rely solely on any information generated by AI, aggregated, or sourced or written otherwise on this site, for investment, financial, or other decisions. aVenture assumes no responsibility for inaccuracies, omissions, or hallucinations. You must independently verify all data from primary sources. Use of this platform constitutes your waiver of claims for reliance-based damages, including negligent misrepresentation. To report an error, request a correction, or dispute information about a company or individual, contact us via our request data updates form.

Loading

Somu Subramaniam - aVenture Research

Somu Subramaniam

AddedMar 31, 2024

UpdatedOct 12, 2026

Somu Subramaniam

Somu Subramaniam

Board Member, Receptor BioLogix

Somu Subramaniam's Career

Receptor BioLogix

Create your profile now and gain access to exclusive deals and high-potential startups.

aVenture product preview

aVenture product preview

aVenture product preview

Series A

$33.6M

Palo Alto, CA, US

Board Member· Board

Trellis Bioscience

Series B$28.6MSan Francisco, CA, US

Board Member· Board

RF Arrays

Public$6.8MPortland, OR, US

Board Member· Board

Resolve Therapeutics

$8.9MKirkland, WA, US

Board Member· Board

Svelte Medical Systems

Series A$128.4MNew Providence, NJ, US

Board Member· Board

Proterixbio

Series D$100.3MBillerica, MA, US

Board Member· Board

Achronix Semiconductor

Series C$135.8MSan Jose, CA, US

Board Member· Board

TigerConnect

Late Stage Private$446.4MSanta Monica, CA, US

Board Member· Board

People Similar to Somu Subramaniam

John FletcherBoard Member · Fletcher Spaght

Fred MiddletonBoard Member · Chimerix

Leadership at Receptor BioLogix

Thomas A GlazeBoard Member

Bill NewmanBoard Member

Similar to Receptor BioLogix

Receptor Life SciencesSeattle, WA, USDrug Delivery, Therapiesest. 2015Receptor Life SciencesSeattle, WA, US · est. 2015

Receptor Life Sciences: Biotech firm specializing in therapies for nervous system disorders and drug-delivery technologies.

Series A · $46.3M12

Biolex TherapeuticsPittsboro, NC, USBiologics, Pharmaceuticalsest. 1997Biolex TherapeuticsPittsboro, NC, US · est. 1997

Biolex, Inc.: US-based clinical developer of pharmaceuticals, specializing in biologics and therapeutic proteins.

Public · $196.7M15

Nerx BiosciencesIndianapolis, IN, USCancer Therapeuticsest. 2009Nerx BiosciencesIndianapolis, IN, US · est. 2009

US-based NĒRx BioSciences Inc, founded in 2009, specializes in discovering and developing targeted cancer therapeutics.

Seed · $500k11

Judo BioCambridge, MA, USTherapeuticsJudo BioCambridge, MA, US

Judo Bio, a stealth-mode biotech firm, pioneers precision therapeutics for genetic diseases, aiming to change lives with innovative receptor targeting.

Leadership at Trellis Bioscience

Stote EllsworthBoard Member

Lawrence KauvarFounder

Tom LavinBoard Member

Stefan RyserBoard Member

Larry KauvarBoard Member

John H. FriedmanBoard Member

Similar to Trellis Bioscience

TrueBindingMenlo Park, CA, USAntibody Drugsest. 2015TrueBindingMenlo Park, CA, US · est. 2015

TrueBinding, based in Menlo Park, US, pioneers in developing monoclonal antibody drugs for various diseases.

Series D · $247.2M175

Leadership at RF Arrays

Chandra DeshpandeyFounder

Similar to RF Arrays

Guerrilla RFGreensboro, NC, USRFICest. 2013Guerrilla RFGreensboro, NC, US · est. 2013

Guerrilla RF: A fabless semiconductor firm supplying RFICs and MMICs to wireless OEMs.

Public · $33M62

RfmicronAustin, TX, USIntegrated Circuits, RFID Tagsest. 2006RfmicronAustin, TX, US · est. 2006

RFMicron: A leading producer of integrated circuits for RFID tags and wireless sensors.

Public · $5.7M21

RF IndustriesSan Diego, CA, USRF Connectors, Wireless Dataest. 1979RF IndustriesSan Diego, CA, US · est. 1979

RF Industries: Designing, manufacturing, and distributing RF connectors and wireless data transmission products.

BitWave SemiconductorLowell, MA, USSemiconductors, Test Equipmentest. 2004BitWave SemiconductorLowell, MA, US · est. 2004

BitWave Semiconductor designs and manufactures RF integrated circuits, serving customers across the US.

Series C · $27.6M30

Leadership at Resolve Therapeutics

James PosadaFounder

Similar to Resolve Therapeutics

Resolvyx PharmaceuticalsCambridge, MA, USTherapeuticsest. 2001Resolvyx PharmaceuticalsCambridge, MA, US · est. 2001

Resolvyx Pharmaceuticals: Developing lipid-based therapeutics for inflammatory diseases.

Series A · $20.7M30

Resolys BioDelanson, NY, USDrug Development, Therapeuticsest. 2016Resolys BioDelanson, NY, US · est. 2016

Resolys Bio: A NY-based biotech firm developing therapies for acute, chronic disorders and TBI.

Resilience TherapeuticsDuxbury, MA, USTherapeuticsest. 2014Resilience TherapeuticsDuxbury, MA, US · est. 2014

Resilience Therapeutics: Innovating cures for PTSD and stress-related diseases through proprietary drug discovery.

Receptor BioLogixPalo Alto, CA, USTherapeuticsest. 2003Receptor BioLogixPalo Alto, CA, US · est. 2003

Receptor BioLogix, Inc. develops receptor-based therapeutics for cancer and other diseases in the US.

Series A · $33.6M30

Leadership at Svelte Medical Systems

Richard DakersBoard Member

Mina SoochBoard Member

Bob FischellBoard Member

Bob CroceBoard Member

Bob FlanaganBoard Member

Similar to Svelte Medical Systems

NovostentMountain View, CA, USMedical Devices, Stentsest. 2003NovostentMountain View, CA, US · est. 2003

NovoStent Corp: Innovating stent technologies for vascular treatments across the US healthcare sector.

Series B · $14.4M6

Leadership at Proterixbio

Mark LundstromBoard Member

Grace ColónBoard Member

Edward CrawleyBoard Member

Similar to Proterixbio

TransceraLlanura, MA, USBiotechest. 2020TransceraLlanura, MA, US · est. 2020

Transcera: A pioneering biotech firm revolutionizing chronic disease treatment through innovative biology.

Pre-Seed · $1M6

ZetaRx BiosciencesSeattle, WA, USMedicalest. 2009ZetaRx BiosciencesSeattle, WA, US · est. 2009

Seattle-based medical organization specializing in healthcare sector since 2009.

MindSet RxArlington Heights, MA, USBiotechest. 2008MindSet RxArlington Heights, MA, US · est. 2008

Massachusetts-based MindSet Rx, a biotech company, provides solutions for neurodegenerative diseases.

ProThera BiologicsProvidence, RI, USDiagnostics, Therapeuticsest. 2001ProThera BiologicsProvidence, RI, US · est. 2001

Prothera Biologics, based in East Providence, US, develops and provides theranostic treatments for sepsis and cancer.

Pre-Seed · $750k6

Leadership at Achronix Semiconductor

Anil KhatodBoard Member

John Lofton HoltCo-Founder

Virantha EkanayakeCo-Founder

Clinton W. KellyCo-Founder

Robert BlakeCEO

Similar to Achronix Semiconductor

EfinixCupertino, CA, USFPGA, Siliconest. 2012EfinixCupertino, CA, US · est. 2012

Efinix, an FPGA company, propels edge computing's future with its innovative silicon platforms.

Public · $9.5M156

Leadership at TigerConnect

Perry WallackBoard Member

Noah J KroloffBoard Member

Brad BrooksCo-Founder & CEO

Garheng KongBoard Member

Robert MittendorffBoard Member

Andrew Brooks, M.D.Co-Founder

Similar to TigerConnect

TwiageNew York City, NY, USHealthcare, Softwareest. 2014TwiageNew York City, NY, US · est. 2014

An award-winning Healthcare IT firm providing communication and workflow solutions for healthcare providers.

Seed · $1.9M25

TrelysSan Francisco, CA, USBiotechnologyest. 2012

TrelysSan Francisco, CA, US · est. 2012

Trelys, Inc.: A San Francisco-based biotechnology company, innovating since 2012.

Seed · $2.6M30

Treeline BiosciencesStamford, CT, USPrecision Medicinesest. 2021Treeline BiosciencesStamford, CT, US · est. 2021

Treeline Biosciences: A biotech firm creating precision medicines for serious conditions.

Series A · $473.3M166

Dren BioFoster City, CA, USTherapeutic Antibodiesest. 2019Dren BioFoster City, CA, US · est. 2019

Dren Bio: A biotech firm in San Carlos, CA, innovating protein-based solutions for disease treatment.

Series B · $130.1M63

East End MedicalMiramar, FL, USMedical Devicesest. 2017

East End MedicalMiramar, FL, US · est. 2017

East End Medical: Innovating catheter-based cardiac procedures with advanced medical devices.

Seed · $1.4M27

Dalent MedicalMiami, FL, USMedical Devicesest. 2017Dalent MedicalMiami, FL, US · est. 2017

Dalent Medical: Innovating ENT care with the world's first universal Sinusleeve™ Balloon for better patient outcomes.

Seed · $2.5M30

Trireme MedicalPleasanton, CA, USCatheters, Medical Devices, Stentsest. 2005Trireme MedicalPleasanton, CA, US · est. 2005

TriReme Medical, Inc. globally provides advanced coronary and arterial disease treatment devices.

Public · $58.9M75

Lattice SemiconductorHillsboro, OR, USProgrammable Logicest. 1983

Lattice SemiconductorHillsboro, OR, US · est. 1983

Lattice Semiconductor: Global designer and marketer of programmable logic and millimeter wave devices.

Public949

Rapid SiliconLos Gatos, CA, USAI Solutions, FPGA IPest. 2021Rapid SiliconLos Gatos, CA, US · est. 2021

RapidSilicon: A leading FPGA-based AI company offering innovative, fast, and efficient open-source solutions.

Series A · $30M129

AeonsemiSanta Clara, CA, USNetwork Devices, Semiconductorsest. 2018AeonsemiSanta Clara, CA, US · est. 2018

Aeonsemi: A fabless IC startup developing DSP-centric products for network communication.

Series A · $11.5M125

iCoreConnectOcoee, FL, USHealthcare Softwareest. 2001

iCoreConnectOcoee, FL, US · est. 2001

iCoreConnect: A cloud-based software firm enhancing productivity and profitability in healthcare, finance, and legal sectors.

Public · $3.6M48

PerfectServeKnoxville, TN, USCommunication, Schedulingest. 1997PerfectServeKnoxville, TN, US · est. 1997

Intelligent healthcare communication solutions for hospitals, practices, and post-acute care.

Series D · $35.9M355

Vital InteractionAustin, TX, USHealthcare Softwareest. 2009Vital InteractionAustin, TX, US · est. 2009

Vital Interaction: Streamlining healthcare communication through specialized software solutions.

Series A · $20M47